Medicus Sciences Prices $80M IPO

Medicus Sciences Acquisition today priced its IPO of 8 million units at $10 per unit. Each consists of one Class A ordinary share, one-ninth of one redeemable warrant, and a contingent right to receive, in certain circumstances, at least two-ninths of one redeemable warrant following an initial business combination.

Units begin trading today on the Nasdaq under MSAC.U. The offering is expected to close Feb. 18.

Medicus will focus on the healthcare industry, particularly the medical technology sector, both in the United States and internationally. Read more.

Total
0
Shares
Related Posts
Read More

Rezolve Secures $250M Commitment in Connection with Armada Acquisition I Deal

The funding may also help the SPAC and Rezolve close their merger. At the Armada-Rezolve deal announcement in December 2021, the combined business was expected to receive $150 million from Armada’s trust, which assumed no redemptions, together with approximately $40 million in additional investment proceeds. However, since then redemptions have whittled the SPAC's trust down to about $36 million.